Long Beach Medical Center Cardiologists Pioneer Innovative Use of GLP-1 Agonists For decades, GLP-1 agonists—a class of medications including generic names like semaglutide and tirzepatide—have been ...
N EW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...
After years of searching for a therapy to combat heart failure with preserved ejection fraction, a research team may have found a breakthrough candidate. Their drug not only improved heart function in ...
A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain people ...
Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...